Retatrutide (GLP-3) is a triple agonist of GLP-1, GIP, and glucagon receptors. This multi-receptor activity has made it the subject of increasing interest in metabolic research. In preclinical models, retatrutide has been studied for its potential to:
Regulate glucose homeostasis Promote weight control and energy balance Influence lipid metabolism Support research on metabolic syndrome and related metabolic pathways. By simultaneously activating three key receptors, Retatrutide provides researchers with a valuable tool to explore integrated approaches to energy metabolism and metabolic health. This compound is intended exclusively for laboratory research use. It is not intended for human consumption.
Reviews
There are no reviews yet.